Danilo Masoni

1 week ago | money.usnews.com | Danilo Masoni

By Danilo MasoniMILAN (Reuters) -A rally in Deutsche Boerse shares illustrates how Europe is bridging a value gap with its Wall Street peers, as fiscal stimulus and a shift in global capital flows help drive a broad re-rating from depressed levels. Following a near 30% rally so far this year, the German exchange operator hit a record valuation of 25 times expected earnings, briefly surpassing all four of its major U.S. competitors by a thin margin for only the second time on record.

1 week ago | gurutrade.com | Danilo Masoni |Dhara Ranasinghe |Kirsten Donovan

European stocks' discount to Wall Street is narrowing German stimulus, defence boost, EU integration helps Deutsche Boerse valuation in line with US peers Banks still below, defence stocks have surged above MILAN, May 29 (Reuters) - A rally in Deutsche Boerse shares illustrates how Europe is bridging a value gap with its Wall Street peers, as fiscal stimulus and a shift in global capital flows help drive a broad re-rating from depressed levels.

3 weeks ago | kfgo.com | Samuel Indyk |Danilo Masoni

By Samuel Indyk and Danilo MasoniLONDON (Reuters) -Europe Inc has weathered the turbulence sparked by U.S. President Donald Trump’s tariff policies to deliver resilient first-quarter earnings, but in spite of the newly-minted trade truce, investors still face a fog of uncertainty. According to LSEG I/B/E/S, first quarter earnings are expected to have increased 1.9% from the same quarter a year ago, marking the fourth straight quarter of growth.

3 weeks ago | money.usnews.com | Samuel Indyk |Danilo Masoni

ReutersFILE PHOTO: The reflection of a digital board showing trading data at the Euronext stock exchange in the La Defense business district in Paris, France, March 10, 2025. REUTERS/Benoit Tessier/File PhotoBy Samuel Indyk and Danilo MasoniLONDON (Reuters) -Europe Inc has weathered the turbulence sparked by U.S. President Donald Trump's tariff policies to deliver resilient first-quarter earnings, but in spite of the newly-minted trade truce, investors still face a fog of uncertainty.

3 weeks ago | gurutrade.com | Danilo Masoni |Amanda Cooper

MILAN, May 12 (Reuters) - European drugmakers stocks fell in early trading on Monday after U.S. President Donald Trump said he would sign an executive order on reducing prescription drug and pharmaceutical prices. Frankfurt-listed shares in Novo Nordisk, AstraZeneca, GSK and Roche Holding were down between 1% and 5%, underperforming a gain in broader European stock index futures. Their declines followed losses in shares of Asian competitors.